首页>
外国专利>
Use of a monoclonal anti CD44 or Fragment of the same Union, in the treatment of Head and neck squamous cell carcinoma (HNSCC) in a Mammal.Where the HNSCC is distinguished by expression of CD44.
Use of a monoclonal anti CD44 or Fragment of the same Union, in the treatment of Head and neck squamous cell carcinoma (HNSCC) in a Mammal.Where the HNSCC is distinguished by expression of CD44.
Use of a monoclonal anti CD44 Antigen or a fragment of a Union of the same for the treatment of Head and neck squamous cell carcinoma (HNSCC) in a HumanWhere the HNSCC is distinguished by the expression of CD44.
展开▼